INTELLIGENT BIO SOLUTIONS INC. Conversion of Stock, Shares Converted
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Conversion of Stock, Shares Converted of 6.25 thousand shares for the 12-month period ending 2025-06-30, per its 10-K filed 2025-08-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2025-08-15
- INTELLIGENT BIO SOLUTIONS INC. conversion of stock, shares converted for the quarter ending 2024-06-30 was 0.00 shares.
- INTELLIGENT BIO SOLUTIONS INC. conversion of stock, shares converted for the quarter ending 2023-12-31 was 6.25K shares.
- INTELLIGENT BIO SOLUTIONS INC. conversion of stock, shares converted for fiscal 2025 was 6.25K shares, a 0.00% change from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. conversion of stock, shares converted for fiscal 2024 was 6.25K shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|
| 2025-06-30 | 6.25K shares 10-K · filed 2025-08-15 | ||
| 2024-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | 6.25K shares 10-K · filed 2024-09-18 | |
| 2024-03-31 | 6.25K shares 10-Q · filed 2024-05-08 | ||
| 2023-12-31 | 6.25K shares 10-Q · filed 2024-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |